Test group:Sacituzumab Tirumotecan
Sponsors
The First Affiliated Hospital of Zhengzhou University, Sun Yat-sen University Cancer Center
Conditions
Advanced biliary tract cancerAdvanced thymic epithelial tumor
Phase 2
A Single-Arm, Single-Center, Phase II Clinical Study of Sacituzumab Tirumotecan (Sac-TMT) for Second-Line or Later Treatment of Advanced or Metastatic Biliary Tract Cancer
Active, not recruitingChiCTR2500112219
Start: 2025-11-15Updated: 2025-11-17
A single-arm, phase II study to evaluate the efficacy and safety of Sacituzumab Tirumotecan in second-line and subsequent treatments for advanced thymic epithelial tumors
Active, not recruitingChiCTR2600122047
Start: 2026-04-20Updated: 2026-04-14